NSPR
vs
S&P 500
Over the past 12 months, NSPR has underperformed S&P 500, delivering a return of -5% compared to the S&P 500's 24% growth.
Stocks Performance
NSPR vs S&P 500
Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.
JP |
Hoya Corp
TSE:7741
|
||
CH |
Alcon AG
SIX:ALC
|
||
DK |
Coloplast A/S
CSE:COLO B
|
||
US |
Align Technology Inc
NASDAQ:ALGN
|
||
KR |
H
|
HLB Inc
KOSDAQ:028300
|
|
CN |
Shenzhen New Industries Biomedical Engineering Co Ltd
SZSE:300832
|
||
US |
Lantheus Holdings Inc
NASDAQ:LNTH
|
||
CA |
Bausch + Lomb Corp
NYSE:BLCO
|
||
UK |
ConvaTec Group PLC
LSE:CTEC
|
||
US |
Merit Medical Systems Inc
NASDAQ:MMSI
|
Performance Gap
NSPR vs S&P 500
JP |
Hoya Corp
TSE:7741
|
||
CH |
Alcon AG
SIX:ALC
|
||
DK |
Coloplast A/S
CSE:COLO B
|
||
US |
Align Technology Inc
NASDAQ:ALGN
|
||
KR |
H
|
HLB Inc
KOSDAQ:028300
|
|
CN |
Shenzhen New Industries Biomedical Engineering Co Ltd
SZSE:300832
|
||
US |
Lantheus Holdings Inc
NASDAQ:LNTH
|
||
CA |
Bausch + Lomb Corp
NYSE:BLCO
|
||
UK |
ConvaTec Group PLC
LSE:CTEC
|
||
US |
Merit Medical Systems Inc
NASDAQ:MMSI
|
Performance By Year
NSPR vs S&P 500
Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.
JP |
Hoya Corp
TSE:7741
|
||
CH |
Alcon AG
SIX:ALC
|
||
DK |
Coloplast A/S
CSE:COLO B
|
||
US |
Align Technology Inc
NASDAQ:ALGN
|
||
KR |
H
|
HLB Inc
KOSDAQ:028300
|
|
CN |
Shenzhen New Industries Biomedical Engineering Co Ltd
SZSE:300832
|
||
US |
Lantheus Holdings Inc
NASDAQ:LNTH
|
||
CA |
Bausch + Lomb Corp
NYSE:BLCO
|
||
UK |
ConvaTec Group PLC
LSE:CTEC
|
||
US |
Merit Medical Systems Inc
NASDAQ:MMSI
|
Competitors Performance
InspireMD Inc vs Peers
Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.
CA |
A
|
Advance Lithium Corp
XTSX:AALI
|
|
US |
G
|
GE Vernova LLC
NYSE:GEV
|
|
NL |
N
|
Nepi Rockcastle NV
JSE:NRP
|
|
US |
Schlumberger NV
NYSE:SLB
|
||
US |
B
|
Baker Hughes Co
NASDAQ:BKR
|
|
ID |
Amman Mineral Internasional Tbk PT
IDX:AMMN
|
||
US |
R
|
Reddit Inc
NYSE:RDDT
|
|
CH |
G
|
Galderma Group AG
SIX:GALD
|
|
US |
Halliburton Co
NYSE:HAL
|
||
IN |
Jio Financial Services Ltd
NSE:JIOFIN
|
InspireMD Inc
Glance View
InspireMD, Inc. operates as a medical device company, which engages in the development and commercialization of the stent platform technology for the treatment of complex vascular and coronary disease. The firm is focusing on the development and commercialization of its MicroNet stent platform technology for the treatment of vascular and coronary disease. Its MicroNet, a micron mesh sleeve, is wrapped over a stent to provide embolic protection in stenting procedures. Its CGuard carotid embolic prevention system (CGuard EPS) combines its MicroNet and a self-expandable nitinol stent in a single device for use in carotid artery applications. Its MGuard Prime Embolic Protection System (MGuard Prime EPS) is marketed for use in patients with acute coronary syndromes, notably acute myocardial infarction (heart attack) and saphenous vein graft coronary interventions (bypass surgery). The company markets and sells MGuard Prime EPS, a bare-metal cobalt-chromium based stent, for the treatment of coronary disease in the European Union. The company is also developing a neurovascular flow diverter (NGuard), which is an endovascular device.